Skip to main content

Table 3 Base-case utility values

From: Long-term cost effectiveness of ticagrelor in patients with acute coronary syndromes in Thailand

Parameters Value Sources
One-year decision tree   
Ticagrelor   
No event 0.873 PLATO [7], Nikolic [8]
Non-fatal MI 0.811 PLATO [7], Nikolic [8]
Non-fatal stroke 0.735 PLATO [7], Nikolic [8]
Death any cause 0.247 PLATO [7], Nikolic [8]
Clopidogrel   
No event 0.876 PLATO [7], Nikolic [8]
Non-fatal MI 0.814 PLATO [7], Nikolic [8]
Non-fatal stroke 0.738 PLATO [7], Nikolic [8]
Death any cause 0.250 PLATO [7], Nikolic [8]
Markov model a   
No event aged less than 70 years 0.875 PLATO [7], Nikolic [8]
No event aged 70–79 years 0.843 PLATO [7], Nikolic [8]
No event aged over 79 years 0.781 PLATO [7], Nikolic [8]
Annual utility decrement MI 1st year Markov model and 2nd year onward 0.147 Tamteeranon [15]
Annual utility decrement stroke 1st year Markov model and 2nd year onward 0.226 Tamteeranon [15]
  1. aThe values in the Markov model are the same for ticagelor and clopidogrel.